Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

China flag China · Delayed Price · Currency is CNY
10.86
-0.09 (-0.82%)
Mar 20, 2026, 1:25 PM CST
Market Cap5.47B +33.2%
Revenue (ttm)924.04M +18.8%
Net Income79.70M +12.7%
EPS0.18 +47.9%
Shares Out499.27M
PE Ratio60.16
Forward PE37.76
Dividend0.05 (0.45%)
Ex-Dividend DateJul 25, 2025
Volume7,995,520
Average Volume17,508,793
Open10.95
Previous Close10.95
Day's Range10.80 - 11.12
52-Week Range6.86 - 15.21
Beta2.05
RSI36.78
Earnings DateMar 24, 2026

About SHE:002728

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People’s Republic of China. The company provides cough and phlegm, kidney, anti-infection, cardiovascular and cerebrovascular, and digestive system drugs, as well as pediatrics, dermatology, tuberculosis, respiratory, rheumatology, nephrology, and endocrinology medicines. Its chemical raw materials and products include aluminum carbonate, phenytoin, ferrous... [Read more]

Sector Healthcare
Founded 2002
Employees 1,341
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002728
Full Company Profile

Financial Performance

In 2024, SHE:002728's revenue was 687.79 million, a decrease of -35.55% compared to the previous year's 1.07 billion. Earnings were 20.50 million, a decrease of -91.90%.

Financial Statements